AI & CRISPR vs. Cancer, Tesla's China AI Push, and Quantum Leaps | Tech News Digest
AI and CRISPR Identify New Kidney Cancer Drug Targets Researchers in the UK and Korea have developed a new machine learning pipeline to identify novel drug targets for clear cell renal cell carcinoma (ccRCC), a common type of kidney cancer. The innovative framework integrates single-cell RNA sequencing with CRISPR screens and protein network analysis to pinpoint tumor-specific vulnerabilities. This AI-driven approach identified 96 potential drug targets and 39 existing FDA-approved compounds for repurposing. Preclinical tests revealed that several of these drugs, including Ribociclib and Dasatinib, were significantly more effective than current standard treatments across all tested renal cancer cell lines. This research, published in npj Drug Discovery, focuses on targeting the tumor’s intrinsic weaknesses. ...